Issue 24, 2023
From the journal:

CrystEngComm

Correction: Molecular adduct of amantadine ferulate presents a pathway for slowing in vitro/vivo releases and raising synergistic antiviral effects via dual optimization salification strategy

Yuan-Yuan Niu,a   Ling-Yang Wang,a   Yue-Ming Yu,a   Yan-Tuan Li, ORCID logo *ab   Zhi-Yong Wu*a  and  Cui-Wei Yan*a  

* Corresponding authors

a School of Medicine and Pharmacy, College of Marine Life Science, Ocean University of China, Qingdao, Shandong 266003, P.R. China
E-mail: yantuanli@ouc.edu.cn, wuzy@ouc.edu.cn, cuiweiyan@ouc.edu.cn

b Laboratory for Marine Drugs and Bioproducts, Qingdao National Laboratory for Marine Science, Qingdao, Shandong, P.R. China

Abstract

Correction for ‘Molecular adduct of amantadine ferulate presents a pathway for slowing in vitro/vivo releases and raising synergistic antiviral effects via dual optimization salification strategy’ by Yuan-Yuan Niu et al., CrystEngComm, 2021, 23, 4389–4401, https://doi.org/10.1039/D1CE00382H.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D3CE90084C
Article type
Correction
Submitted
05 Jun 2023
Accepted
05 Jun 2023
First published
08 Jun 2023
This article is Open Access
Creative Commons BY license

CrystEngComm, 2023,25, 3578-3578

Permissions

Request permissions

Correction: Molecular adduct of amantadine ferulate presents a pathway for slowing in vitro/vivo releases and raising synergistic antiviral effects via dual optimization salification strategy

Y. Niu, L. Wang, Y. Yu, Y. Li, Z. Wu and C. Yan, CrystEngComm, 2023, 25, 3578 DOI: 10.1039/D3CE90084C

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements